Cardiovascular progenitors derived from induced pluripotent stem cells (iPS) improve heart function after myocardial infarction

Andreas Martens, Christina Mauritz, Sebastian Rojas, Tilman Schnick, Robert Zweigerdt, Axel Haverich, Ulrich Martin & Ingo Kutschka
Introduction: Induced pluripotent stem (iPS) cells are obtained from somatic cells by reprogramming the genome to a pluripotent state. Cardiovascular progenitor cells derived from iPS cells might be useful for autologous cellular cardiomyoplasty. Flk1 has been described as an early mesodermal and precardiac[for full text, please go to the a.m. URL]